Research analysts who have asked questions during Concord Medical Services Holdings earnings calls.
Recent press releases and 8-K filings for CCM.
Concord Medical Reports First Half 2025 Financial Results
CCM
Earnings
Demand Weakening
New Projects/Investments
- Total net revenues for Concord Medical in the first half of 2025 were RMB200.6 million (US$28.0 million), representing an 8.3% decrease from RMB218.8 million in the same period last year.
- The company reported a gross loss of RMB4.3 million (US$0.6 million) in the first half of 2025, a significant improvement from a gross loss of RMB41.6 million in the first half of 2024, with the gross loss margin improving from 19.0% to 2.1%.
- Net loss attributable to ordinary shareholders for the first half of 2025 was RMB27.1 million (US$3.8 million), a substantial improvement compared to RMB172.3 million in the same period last year.
- Basic and diluted loss per share for Class A and Class B ordinary shares was RMB0.21 (US$0.03) in the first half of 2025, compared to RMB1.31 in the same period last year.
- The improvement in financial results was primarily driven by an 11.1% increase in hospital business net revenues due to the commencement of proton therapy operations, despite a 41.3% decrease in network business net revenues due to decreased demand and non-renewal of operating lease contracts.
Sep 26, 2025, 11:35 AM
Concord Medical Reports First Half 2025 Financial Results
CCM
Earnings
Demand Weakening
New Projects/Investments
- Concord Medical reported total net revenues of RMB200.6 million (US$28.0 million) for the first half of 2025, representing an 8.3% decrease from the same period last year.
- The company significantly reduced its net loss attributable to ordinary shareholders to RMB27.1 million (US$3.8 million) in the first half of 2025, compared to RMB172.3 million in the first half of 2024.
- Basic and diluted loss per share improved to RMB0.21 (US$0.03) for the first half of 2025, down from RMB1.31 in the prior year period.
- Adjusted EBITDA improved to negative RMB62.2 million (US$8.7 million) in the first half of 2025, compared to negative RMB148.0 million in the same period last year.
- Hospital business net revenues increased by 11.1% to RMB153.0 million (US$21.4 million), mainly due to the commencement of proton therapy operations, while network business net revenues decreased by 41.3% to RMB47.6 million (US$6.6 million).
Sep 26, 2025, 11:30 AM
Quarterly earnings call transcripts for Concord Medical Services Holdings.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more